Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Provision of signed and dated written informed consent prior to any study specific procedures
Men or women, age ≥ 18 years. Women must be of non-childbearing potential or stable on a highly effective contraceptive method for at least 3 months prior to Visit 1 and be willing to continue on the chosen contraceptive method throughout the study.
Be a non-smoker or ex-smoker who has stopped smoking for \>6 months prior to study start
A history of asthma for at least 6 months.
Body Mass Index (BMI) 19-30 kg/m2
You may not be if
Significant disease or disorder which, in the opinion of the Investigator, may either put the patient at risk because of participation in the study, or influence the result of the study, or the patient's ability to participate in the study
History of severe allergy/hypersensitivity or ongoing allergy/hypersensitivity, as judged by the Investigator or history of hypersensitivity to β2-agonists in general or to AZD3199 and/or excipients
Prolonged QTcF \> 450 msec or shortened QTcF \<340 msec
History of alcohol/drug abuse or excessive intake of alcohol as judged by the Investigator
Pregnancy or lactation
Clareo Health | Evaluation of the Pharmacokinetics and the Pharmacodynamics of Different Dry Powder Inhalation Formulations of AZD3199 in Patients With Asthma
